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The pork tapeworm (Taenia solium) is a parasitic helminth that imposes a major health and
economic burden on poor rural populations around the world. As recognized by the World
Health Organization, a key barrier for achieving control of T. solium is the lack of an accurate
and validated simulation model with which to study transmission and evaluate available con-
trol and elimination strategies. CystiAgent is a spatially-explicit agent based model for T.
solium that is unique among T. solium models in its ability to represent key spatial and envi-
ronmental features of transmission and simulate spatially targeted interventions, such as
ring strategy.
Methods/Principal findings
We validated CystiAgent against results from the Ring Strategy Trial (RST)–a large cluster-
randomized trial conducted in northern Peru that evaluated six unique interventions for T.
solium control in 23 villages. For the validation, each intervention strategy was replicated in
CystiAgent, and the simulated prevalences of human taeniasis, porcine cysticercosis, and
porcine seroincidence were compared against prevalence estimates from the trial. Results
showed that CystiAgent produced declines in transmission in response to each of the six
intervention strategies, but overestimated the effect of interventions in the majority of vil-
lages; simulated prevalences for human taenasis and porcine cysticercosis at the end of the
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trial were a median of 0.53 and 5.0 percentages points less than prevalence observed at the
end of the trial, respectively.
Conclusions/Significance
The validation of CystiAgent represented an important step towards developing an accurate
and reliable T. solium transmission model that can be deployed to fill critical gaps in our
understanding of T. solium transmission and control. To improve model accuracy, future
versions would benefit from improved data on pig immunity and resistance, field effective-
ness of anti-helminthic treatment, and factors driving spatial clustering of T. solium infec-
tions including dispersion and contact with T. solium eggs in the environment.
Author summary
Neurocysticercosis, caused by the ingestion of Taenia solium eggs, is a major cause of
human epilepsy around the world. A wide spectrum of tools to fight T. solium is are now
available and include antiparasitic treatment for pigs and humans, porcine vaccines, and
sanitation improvements; however, the ideal combination of interventions applied to pop-
ulations to maximize effectiveness and feasibility is not known. Transmission models are
one tool that can be used to compare and evaluate different intervention strategies, but no
currently available T. solium models have been tested for accuracy. In this research, we
validated our model (“CystiAgent”) by comparing simulations of the model to the results
of a large-scale trial testing a variety of T. solium control interventions. The model was cal-
ibrated using observed epidemiological data from these villages and evaluated for its abil-
ity to reproduce the effect of T. solium control interventions. The validation showed that
the model was able to reproduce the baseline levels of disease, but generally overestimated
the effect that each intervention would have on transmission. These results will allow us to
identify limitations of the current model to improve future versions, and represent a step
forward in the creation of a tool to design and evaluate future programs to control and
eliminate T. solium.
Introduction
Cysticercosis is a neglected tropical disease (NTD) that exacts a substantial health and eco-
nomic burden in low-income countries. The global burden of cysticercosis includes approxi-
mately 5 million people with neurocysticercosis (NCC) or epilepsy due to NCC [1] and
hundreds of millions of dollars in annual livestock losses from discarded pork [2].
Although global eradication of T. solium transmission is unlikely in the short-term, local
control or elimination is now possible [3,4] due to the availability of new tools that can be
deployed to interrupt transmission. These include effective treatment of taeniasis [5,6] and
porcine cysticercosis [7,8], improved diagnostic tests [9,10], and a vaccine to prevent pig infec-
tion [11,12]. In 2012, shortly after the success of a large-scale elimination demonstration in
Peru that effectively implemented many of these tools [3], the World Health Organization
(WHO) declared ambitious targets for global control and elimination of T. solium. They called
for validated control strategies to be identified by 2015, and for these strategies to be scaled
and implemented in several countries by 2020 [13]. Due, in part, to the high cost and lengthy
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time required to conduct prospective trials, optimal strategies for T. solium control have not
yet been identified, and the 2020 targets for large-scale implementation have not been met.
More recently, WHO called for transmission models to be deployed to optimize control strate-
gies and reach agreed-upon targets for control [14], a goal that was recently reinforced in the
WHO’s 2030 goals for T. solium control [15].
To this end, six models of T. solium transmission have been published to date that attempt
to fill this gap [16–21]. Despite preliminary use of these models to compare and contrast avail-
able control strategies, there are significant concerns about the validity of these models that
must be addressed before reliable policy recommendations can be made. The most important
deficit of existing T. solium models is that none have been validated against data from prospec-
tive trials carried out in the field. Comparison of model predictions with observed outcomes is
a critical step for ensuring the validity of a model, and up until recently, a lack of data from
prospective trials has prevented such validation.
Beyond a lack of validation, prior models have not incorporated certain features of T.
solium transmission that may be important for model accuracy. First, no prior model has a
spatially explicit structure, meaning that pigs and humans are assumed to mix homogenously
to transmit the parasite, a limitation that was highlighted in a recent systematic review of avail-
able T. solium models [22], and in a report outlining key modeling improvements needed to
meet the WHO 2030 goals [15]. Spatially clustered transmission patterns have been well-docu-
mented in endemic villages [23–26], and spatially targeted control strategies (e.g., “ring strat-
egy”) have shown success in field trials [27]. Second, the lack of an open population structure
that allows for human travel and migration is a key limitation of existing T. solium models.
The lack of such a structure prevents existing models from capturing rebounds in transmission
that may occur after elimination has been achieved due to movement of infected people or
pigs in to an area with successful elimination [28,29]. Together, these design features may lead
existing models to over-estimate intervention effectiveness and over-estimate the likelihood of
achieving control and elimination targets [30,31].
In order to address the above limitations, we developed a novel agent-based model (ABM)
called “CystiAgent” [21]. Notably, CystiAgent includes a spatial structure and open popula-
tion, which allows it to represent key aspects of the T. solium life-cycle, and facilitates the eval-
uation of spatially targeted control interventions. In the current study, we present results from
our validation of CystiAgent using data from the RST, a cluster-randomized trial conducted in
northern Peru that included 23 villages and 6 unique control strategies: four spatially targeted
ring interventions and two mass applied interventions [32]. Our objective was to evaluate the
ability of CystiAgent to replicate baseline levels of transmission through model calibration and
to evaluate the accuracy of the model for predicting observed reductions in transmission when
control strategies were applied.
Methods
Model description
Model structure. CystiAgent is a spatially explicit ABM developed in NetLogo 6.0.4
(Northwestern University, Evanston, IL), an open-access ABM software ideal for representing
spatial processes in a graphical user interface. The full model code is available at http://
modelingcommons.org/browse/one_model/6268, and an in-depth model description with
sensitivity analyses of model parameters was previously published by Pray et al. [21].
Agents. CystiAgent has two classes of agents–humans and pigs–that interact and transmit
T. solium in a spatial environment. Humans may be infected with the adult-stage intestinal
tapeworm (i.e., T. solium taeniasis) through consumption of infected pork, and pigs may be
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infected with larval-stage metacestodes (i.e., porcine cysticercosis) through contact with T.
solium eggs or proglottids in the environment. Exposure to eggs may cause light cyst infection
(<100 cysts), and exposure to proglottid segments may lead to heavy cyst infection (� 100
cysts); either may lead to seropositivity [33–35]. The different exposure-infection pathways for
heavy and light cyst infection in pigs were based on a combination of biologic plausibility and
consistency with prior transmission models [18,19]. Pig infection is a categorical state variable
(susceptible, light infection, heavy infection), and individual T. solium eggs or cysts are not
agents in the model. Therefore, the cut-off value of 100 cysts between light and heavy cyst
infection serves only to allow for translation of prevalence from serological studies and to fit
the conceptual distinction between transmission routes for light and heavy infection, but is
not numerically represented in the model. Human cysticercosis, including NCC or NCC-
related seizure disorders, is not included in this model.
Environment. The model environment consists of households in villages that are spatially
distributed according to a set of input coordinates that can be assigned to represent real vil-
lages if household coordinates are known. Household characteristics such as the presence of
latrines or corrals to contain pigs are assigned at baseline and the houses are populated with
humans and pigs.
Processes and flow. CystiAgent consists of a sequence of biological and behavioral pro-
cesses that cycle continuously to propagate the T. solium life-cycle (Fig 1).
1. Live pig trade. Infected pigs that are due for slaughter may be sold live within the village
and then slaughtered at home by the buyer, or exported out of the village. Infected pigs
from external villages may also be imported into the village through the live pig trade.
2. In-house slaughter and pork sale. Infected pigs may be slaughtered by their owners. The
resulting pork meat may then be consumed at home and/or sold to other households.
3. Pork consumption. When consumed pork is infected with T. solium cysts, all members of
the consuming households are exposed to potential tapeworm infection.
4. Human infection. Humans who consume infected pork may acquire a tapeworm infection
(or remain in a susceptible state), a stochastic process determined by two locally calibrated
tuning parameters (one each for consuming lightly and heavily infected pork). The intesti-
nal tapeworm reaches maturity after 8 weeks [36], and begins expelling infectious eggs at
that time. Tapeworm infections naturally clear after a stochastically determined duration
[36,37].
5. Human travel. Humans that are designated as travelers leave the community at regular
intervals, may contract tapeworm infections through consumption of infected pork while
traveling to other endemic areas, return to the village after travel and resume contamination
of their environment.
6. Open defecation. Human tapeworm carriers that do not own or use a latrine release T.
solium eggs and proglottid segments into the environment surrounding their household
location. When tapeworm infections clear, humans stop releasing proglottid segments, but
contamination of the environment with eggs persists until the eggs naturally degrade
according to an exponential decay function [38].
7. Pig roaming and foraging. Pigs that are designated as free-roaming (i.e., not contained in
corrals) are exposed to T. solium proglottids and eggs that are present in their home-range
areas.
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Fig 1. Transmission of Taenia solium in CystiAgent. Panel A (top): 1) Live pig trade: infected (live) pigs are sold to other households inside and outside the village, and
imported from outside; 2) in-house slaughter and sale of pork to other households 3) pork consumption: potentially infected pork is consumed by household members; 4)
human infection (see panel B for details); 5) human travel: humans travel to other endemic villages where they may acquire tapeworm infections through pork
consumption; 6) open defecation: humans may practice open outdoor defecation; 7) pig roaming and foraging: free-roaming pigs consume potentially infectious eggs
present in the environment; 8) pig infection (see panel B for details). Panel B (bottom): Susceptible pigs (S) may be heavily exposed (EH) by consuming T. solium proglottid
segments in the environment or through the stochastic parameter heavy-all, which is a probability of exposure applied to all pigs, or be lightly exposed (EL) by consuming
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8. Pig infection. Pigs that are exposed to proglottid segments may develop heavy cyst infec-
tion, while pigs exposed to eggs in the environment may develop light cyst infection. Either
may result in seropositivity. Free-roaming pigs are exposed to an additional risk of exposure
that is proportional to the number of tapeworm carriers in the village and naïve to the pig’s
location. This represents exposure to eggs that results from roaming and consumption of
human feces from open defecation sites outside of the home area. Progression of T. solium
exposure (eggs or proglottids) to seropositivity or cyst infection (or return to a susceptible
state) is a stochastic process determined by a set of four locally calibrated tuning parameters
(see below). Mature cyst infection occurs immediately after exposure without a pre-patent
maturation period. Pigs that are lightly infected may progress to heavy cyst infection if
exposure to proglottid segments occurs; otherwise, infected or seropositive pigs remain in
that state until slaughter, with no option for recovery unless a treatment intervention is
applied.
Parameters
Each of the above processes is defined mathematically by a probability distribution and corre-
sponding parameter(s) (Table 1). The majority of parameters were derived from observational
studies conducted in northern Peru [21,32], but some were based on expert opinion and litera-
ture review. Model parameters, source data, and in-depth sensitivity analyses on model param-
eterization are described in detail in Pray et al [21].
Fitting
Apart from the biological and behavioral parameters included in the model, CystiAgent uti-
lizes a set of tuning parameters to adjust the probabilities of infection to match the observed
prevalence of human and pig infection in each trial village. To do this, the model includes
eight tuning parameters that represent different probabilities of exposure or infection for pigs
or humans. Since these parameters represent complex sequences of unknown probabilities
and cannot be determined through primary data collection or literature review, we adopted an
approximate Bayesian computation (ABC) algorithm [40] to computationally derive their val-
ues for this analysis (this is described in detail below).
Model validation—ring strategy trial
Trial design. The RST was a cluster-randomized trial comparing six unique population-
level interventions designed to control T. solium transmission. The trial was carried out in 23
villages in the Piura region of northern Peru over a period of 24 months (2015–2017) [32].
Trial villages were randomly divided into six arms each receiving unique intervention designs
(Table 2). Four of the six arms received some variation of ring strategy. This is an approach
that targets anthelminthic treatment to humans and pigs that live within 100 meters of pigs
found to be heavily infected through non-invasive tongue palpation [27,41]. Between the four
ring-strategy arms, the approach varied based on the intervention applied within 100-meter
rings. For humans, the two options included presumptive treatment of human taeniasis with
T. solium eggs in the environment or through light-all. Pigs with heavy or light exposure may develop heavy (IH) or light (IL) cyst infection through the stochastic tuning
parameters light-inf and heavy-inf. Pigs with heavy or light exposure may become seropositive (IS) based on the stochastic tuning parameters light-sero and heavy-sero.
Susceptible humans (S) may be heavily exposed (EH) or lightly (EL) exposed to cysts after eating infected pork from a heavily or lightly infected pig. Consumption of
heavily or lightly infected pork cause tapeworm infection (I) in humans based on the stochastic tuning parameters ph2h and pl2h, respectively. Icons provided by Noun
Project and created by Pariphat Sinma, Ikopah, Dennis, Berkah, Giorgiana Ionescu, Nabilauzwa and Alexsandr Vector.
https://doi.org/10.1371/journal.pntd.0009885.g001
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Table 1. CystiAgent model parameters.
Parameter Description Parameter Name Distribution Value (range, if applicable) Source
Village input features (village-specific)�
Humans per household humans-per-hh Poisson 3.8 (3.32–4.94) RST
Proportion of households raising pigs prop-pig-owners Binomial 0.49 (0.25–0.75) RST
Pigs per pig-raising household pigs-per-hh Exponential 2.43 (1.74–4.21) RST
Corral prevalence among pig-owner households prop-corrals Binomial 0.50 (0.23–0.92) RST
Latrine prevalence prop-latrines Binomial 0.64 (0.19–0.97) RST
Live pig trade
Proportion of pigs sold prior to slaughter pigs-sold Binomial 0.51 HH
Proportion of sold pigs exported pigs-exported Binomial 0.73 HH
Rate of pigs imported from endemic areas
(imports / pig / week)
pig-import-rate Constant 0.00105 HH
Prevalence of cyst infection among imports import-prev Binomial 0.134 HH
Proportion of infected imported pigs with light cyst burden light-to-heavy Binomial 0.76 HH
In-house slaughter and pork sale




Proportion of pork consumed by owner hh-only-pork Binomial 0.40 HH
Proportion of pork sold after slaughter sold-pork Binomial 0.12 HH
Proportion of shared pork eaten by owner shared-pork-hh Binomial 0.8 HH
Human infection
Incubation time to reach tapeworm maturity tn-incubation Constant 8 weeks [36]
Tapeworm lifespan (years) tn-lifespan Normal† Mean = 2 years
SD = 0.96 years
[36,37]
Human travel
Proportion of households with a frequent traveler traveler-prop Binomial 0.42 HH
Frequency of travel to other endemic areas
(every X weeks)
travel-freq Constant 8 weeks HH
Duration of travel travel-duration Exponential† 1.75 weeks HH
Incidence of T. solium taeniasis during travel
(risk / person / week)
travel-incidence Constant 0.00023 [24]
Open defecation
Latrine-use (prop. of households that “always” use latrine) latrine-use Binomial 0.25 [39]
Radius of environmental contamination (meters from home) cont-radius Log-normal† Log-mean = 3.27 (median = 26 meters)
Log-SD = 0.547
[39]
Rate of egg decay in environment (mean survival duration) decay-mean Exponential 8 weeks [38]
Pig roaming and foraging
Proportion of pig households with corrals that “always” corral pigs corral-always Binomial 0.05 [39]
Proportion of pig households with corrals that “sometimes” corral pigs corral-
sometimes
Binomial 0.57 [39]
Proportion of pigs in “sometimes”-corral-households that are corralled prop-corral-
some
Binomial 0.32 [39]
Radius of pig roaming “home-range”
(meters from home)




Probability of human taeniasis upon slaughter of lightly infected pig pl2h Binomial 0.00435 (0.0023–0.0099) Calibration
Probability of human taeniasis upon slaughter of heavily infected pig ph2h Binomial 0.00473 (0.00314–0.0075) Calibration
Probability of exposure to T. solium eggs per human with taeniasis light-all§ Binomial 0.00944 (0.00445–0.0141) Calibration
Probability of exposure to T. solium proglottids per human with taeniasis heavy-all§ Binomial 0.0161 (0.0123–0.0209) Calibration
(Continued)
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two doses of oral niclosamide (NSM), or stool screening for taeniasis with the enzyme-linked
immunosorbent assay for copro-antigen detection (CoAg-ELISA) and repeated follow-up test-
ing and treatment with oral NSM until cure. Some villages in each of these categories received
treatment of pigs with a single oral dose of oxfendazole (OFZ), and others had no pig treat-
ment interventions. All ring interventions were administered in trial villages every 4 months
throughout the 2-year trial-period. The remaining two trial arms received mass treatment of
humans with a single oral dose of NSM every 6 months with and without the addition of por-
cine mass treatment every 4 months. Eligibility criteria for RST included all humans two years
of age or older, and all pigs greater than two months of age and not pregnant.
Table 1. (Continued)
Parameter Description Parameter Name Distribution Value (range, if applicable) Source
Probability of light cyst infection upon contact with to T. solium eggs light-inf Binomial 0.286 (0.0137–0.0582) Calibration
Probability of heavy cyst infection upon contact with to T. solium
proglottids
heavy-inf Binomial 0.00654 (0.0041–0.0116) Calibration
Probability of pig seropositivity upon exposure to T. solium eggs light-sero Binomial 0.316 (0.095–0.67) Calibration
Probability of pig seropositivity upon exposure to T. solium proglottids heavy-sero Binomial 0.286 (0.031–0.82) Calibration
� Village input values were measured and applied separately in each village; tuning parameters were calibrated separately for each village; parameter values in these
categories are displayed in this table as the mean and range among villages included in the analysis
† Values for these five parameters (slaughter-age, tn-lifepan, travel-duration, cont-radius, and home-range) were applied at the individual pig, human, or household level
by randomly assigning a value from the specified statistical distribution (all other parameter values were assigned at the village level).
§ Exposure probabilities (“light-all” and “heavy-all”, x) scaled to the current number of tapeworm carriers (HT) according to 1 − (1–x)HT
Abbreviations: RST = Ring Strategy Trial; HH = Household Survey; SD = Standard Deviation
https://doi.org/10.1371/journal.pntd.0009885.t001
Table 2. Summary of interventions and populations in Ring Strategy Trial–Peru, 2015–2017.
Strategy Interventions Population





Ring treatment w/ pig
treatment










Ring screening w/ pig
treatment
Pig tongue screening, human screen-and-treat, pig treat in









Human and pig mass
treatment








�2 villages excluded from ring treatment due to small size and lack of observed transmission
Abbreviations: MDA = Mass drug administration, q = frequency; x = repetitions.
https://doi.org/10.1371/journal.pntd.0009885.t002
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Trial outcomes. Serum samples from all eligible pigs in the trial communities were col-
lected every four months over the 24-month trial period (seven rounds total) and tested with
the enzyme-linked immune-electro transfer blot (EITB). We considered a pig to be seroposi-
tive if two or more of the bands on the EITB assay were reactive [42]. Because necroscopic
examination of pigs to assess true cyst infection was not conducted in the trial, we estimated
the prevalence of porcine cysticercosis at baseline and trial-end using EITB serology and con-
versions from prior necropsy studies in the region. EITB serology is highly sensitive but non-
specific for identifying pigs with active larval cyst infection (seropositivity without infection
may be due to prior resolved cyst infection, exposure without established infection, or cross-
reactivity), thus conversion is needed account for EITB positive pigs without active cyst infec-
tions [33,42]. We estimated that a total of 43.9% of seropositive pigs would be infected with lar-
val cysts (31.1% of seropositive pigs with a light cyst burden of< 100 cysts, and 12.8% with a
heavy cyst burden of�100 cysts), figures that were based on the average of two large necropsy
studies conducted in Peru [34,35]. In addition to estimating the prevalence of cyst infection at
baseline and trial end, we measured the cumulative incidence of EITB seroconversion for each
of four-month intervals throughout the trial. This measure of seroincidence represented the
proportion of new or previously seronegative pigs that became seropositive during the previ-
ous four-month period.
For human taeniasis, all human participants were offered NSM at the conclusion of the
trial, and post-treatment stool samples were analyzed with CoAg-ELISA to evaluate the final-
round prevalence of human taeniasis. Baseline prevalence of human taeniasis, however, was
not directly measured in the RST. We estimated this value using a regression equation that was
developed from a prior cross-sectional study of human taeniasis and porcine cysticercosis in
the region [24]. For this, seroprevalence of (2+ EITB bands) in pigs was used a predictor for
the log-prevalence of human taeniasis. A complete description of statistical methods for out-
come estimation and other validation settings are included in S1 Appendix and village-level
RST outcome are available in S1 Data.
Model validation. Validation attempts were performed individually for each village in the
RST. Two of the 23 villages were excluded from validation because they were either too small
to achieve stable transmission (<10 pigs in the village) or had no heavily infected pigs identi-
fied at baseline, meaning that no ring interventions were applied during RST. This left 21 vil-
lages for model validation. For each village, a unique set of household coordinates and input
characteristics were applied based on RST census data and the model was fit with a unique set
of tuning parameters generated by ABC calibration. Other than these village-specific settings,
the same model structure and parameter values were used in all validation attempts. After cali-
bration was performed, factors influencing calibration accuracy across villages were assessed
using multivariable linear regression with relative errors at baseline as the dependent variable.
Calibration of model tuning parameters. We used an ABC method to estimate values
for the six tuning parameters that define the probabilities of human and pig infection in the
model (pl2h, ph2h, light-inf, heavy-inf, light-all, and heavy-all; see Table 1 for details) and two
serological parameters (light-sero and heavy-sero) defining the probability of antibody response
after exposure for pigs. A unique set of tuning parameters was estimated for each of the 21 vil-
lages. Our ABC method followed a two-stage sequential rejection sampling approach
[40,43,44]. We used a Sobol’ quasi-random sequence [45,46] to sample 5,000 values from a
uniform prior distributions (0 to 1) of each parameter. For each combination of parameter val-
ues, we ran the model though 1000 weeks without interventions and recorded the average
prevalence of taeniasis (humans), light and heavy cyst infection (pigs) and seroincidence (pigs)
across the simulation period. The “sensitivity” package in R was then used to calculate the
Euclidean distance [47,48] between summary statistics and the baseline prevalence observed in
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the field data. We selected the top 1% of model runs that minimized the Euclidean distance
and extracted posterior distributions from the selected parameter sets. With the new generated
posterior distribution, we repeated the rejection sampling algorithm with 10,000 tuning
parameters sets and selected our final parameter values based on the median values of the new
posterior distributions produced for each parameter in this final step. All model simulations
for calibration and validation were executed in R (The R Foundation for Statistical Computing,
Vienna, Austria) and NetLogo on the Amazon Web Service EC2 cloud computing platform
(aws.amazon.com, Seattle, WA). Model simulations were distributed across multiple 72-core
parallel processors using the “parallel” R-package [49] and executed on the EC2 cloud using
the R-Studio Shiny server [50].
Simulation of control strategies. For model validation, all simulations began with a
1000-week burn-in period, followed by the corresponding intervention sequence that was
applied in the RST, and 100-week post-intervention observation period. Intervention
sequences were repeated 1000 times per village for validation. Participation in interventions
among humans and pigs was applied separately in each village and reflected the proportions
that were observed in that village during the RST. The sensitivity and specificity of the CoAg-
ELISA for detecting T. solium taeniasis was set to 96.4% and 100%, respectively based on the
method described by Guezala et al. [9], and the efficacy of NSM for treatment of human taeni-
asis was set at 76.6% for one dose, 86.6% for two doses, and 93.3% for post-screening follow-
up. Treatment of pigs with OFZ was assumed to have an efficacy of 100%. Detailed model set-
tings used for validation are available in S1 Appendix and participation rates used for each vil-
lage are available in S1 Data.
Evaluation of model accuracy. For each RST village, we compared the model-predicted
prevalence of human taeniasis, porcine cysticercosis, and pig seroincidence with the values
observed in the trial (or values estimated from trial observations). For graphical comparison,
the plots of model-predicted outcomes show the absolute and relative error of the median of
the 1000 model runs compared to the values observed in the trial or generated from trial obser-
vations. The relative error and absolute errors between an observed Pobs and the median simu-
lated prevalence Psim is defined as follows:




Baseline calibration for ring strategy trial
Among the 21 villages evaluated in the RST, the median observed prevalence of human taenia-
sis and porcine cysticercosis at baseline were 2.2% (range: 0.9% to 3.8%) and 19.2% (range:
6.3% to 27%), respectively. Median porcine seroincidence per 4-month period at baseline was
44.2% (range: 5.3% to 78%).
The ABC calibration step allowed CystiAgent to accurately replicate observed baseline prev-
alence for all villages and disease outcomes (Fig 2). The median absolute difference between
simulated and observed taeniasis prevalence at baseline was +0.09 percentage points (range:
-0.20 to +0.63 percentage points), corresponding to a median relative error of +4.9% (range:
-18.5% to +33.3%). For porcine cysticercosis, the median absolute difference between simu-
lated and observed prevalence at baseline was +0.58 percentage points (range: -1.6 to +3.1 per-
centage points), with a median relative error of +3.8% (range: -9.3% to +22.8%). For porcine
seroincidence, median absolute differences and relative errors between simulated and
observed at baseline were +1.8 percentage points (range: -3.4 to 5.3 percentage points) and
+3.2% (range: -4.7% to +27.9%), respectively. Overall, calibration accuracy was high across all
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Fig 2. Relative (top) and absolute (bottom) errors during validation of CystiAgent against results from the Ring
Strategy Trial for human taeniasis (left) and porcine cysticercosis (right) at baseline (month 0) and trial-end
(month 24) (n = 21 villages). For ring treatment (n = 6 villages), ring screening (n = 8 villages) and mass treatment
(n = 7 villages villages), interventions with (white) and without (grey) pig treatment are designated by the background
color of the plot area. Three villages (570, 578, and 585) had no human taeniasis identified at trial-end and relative
errors were not able to be calculated.
https://doi.org/10.1371/journal.pntd.0009885.g002
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villages, and no village factor in the model, including number of households, use of corrals and
use of latrines were associated with an improvement or decline in the accuracy of baseline cali-
bration after evaluating calibration errors in a multivariable linear regression model.
Accuracy of intervention effects
When RST intervention strategies were simulated in CystiAgent, the model overestimated the
intervention effects for taeniasis and porcine cysticercosis in the majority of villages. The
median prevalence of taeniasis observed at the conclusion of the RST was 0.55% (range: 0 to
4.3%), with elimination of taeniasis by trial-end in 3 of the 21 villages. CystiAgent predicted
elimination of taeniasis at trial-end in 12 of 21 villages and median prevalence across all vil-
lages of 0% (range: 0 to 0.37%), which was 0.53 percentage points less (range: 4.3 to +0.36 per-
centage points) than the observed prevalence at trial-end.
The median prevalence of porcine cysticercosis observed at the conclusion of the RST was
8.8% (range: 2.0 to 23.3%). CystiAgent predicted a trial-end median prevalence of 2.2% (range:
0% to 6.4%), which was a median of 5.0 percentage points less (range: 18.9 to +4.1 percentage
points) than the observed prevalence of porcine cysticercosis at trial-end. None of the villages
achieved complete elimination of taeniasis and porcine cysticercosis by the end of the trial;
however, CystiAgent predicted T. solium elimination in two of the 21 villages at the end of the
trial, and six villages by the end of the 100-week post-intervention period.
Between the three primary intervention types compared in RST (ring screening, ring treat-
ment, and mass treatment), CystiAgent predicted similar and substantial reductions in taenia-
sis and porcine cysticercosis by trial-end (Fig 3). This differed from observed results of the
trial, which found that ring-screening and mass-treatment led to larger reductions in preva-
lence compared to ring-treatment, although all three intervention types were effective control
strategies against human taeniasis and porcine cysticercosis. Prediction errors for taeniasis and
porcine cysticercosis at trial-end were greatest for ring treatment (-1.0 and -7.4 percentage
points for taeniasis and porcine cysticercosis, respectively), and less for ring screening (-0.47
and -3.1 percentage points), and mass treatment (-0.45 and -5.2 percentage points).
In villages where antihelminthic treatment of pigs was added to each of the three primary
intervention types, CystiAgent predicted more dramatic reductions in the prevalence of porcine
cysticercosis compared to interventions with human screening or treatment alone. The predicted
effect of pig treatment on human taeniasis prevalence was minimal. Graphs of model predictions
versus RST outcomes split by interventions with and without pig treatment are available in S1
Fig. Despite model predictions, an additive effect of pig treatment was not observed in RST,
which led to increased prediction errors in villages where pig treatment was applied.
The accuracy of CystiAgent with respect to porcine seroincidence as a measured outcome in
RST was similar to other outcomes, with the model slightly overestimating the intervention effect
in most villages. Across all 21 RST villages, the median observed porcine seroincidence in the
final 4-month study interval was 12.6% (range: 3.3% to 45%), which corresponds to a median
decline of 24.8 percentage points (range: 1.6 to 71 percentage points) from baseline. In CystiA-
gent, the median simulated seroincidence in the final 4-month study interval was 6.1% (range:
0% to 25.7%), which corresponds to a median absolute difference of 6.6 percentage points lower
(range: -36.2 to +18.7 percentage points) than the observed seroincidence during that interval.
Comparing the accuracy of seroincidence simulations across intervention types in RST, all
three overestimated intervention effects by a similar degree by trial-end (Fig 4). CystiAgent
predicted seroincidences during final 4-month study interval that were a median of 6.2, 7.0,
and 6.6 percentage points less than observed seroincidence in ring screening, ring treatment,
and mass treatment villages, respectively. Despite this consistency at trial-end, model accuracy
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varied by intervention type at mid-study time-points 2 and 3 (months 4 and 8 of RST), when
CystiAgent failed to replicate a steep early decline in seroincidence that was observed only in
ring screening villages.
Discussion
Development and validation of a T. solium transmission model was identified as a key goal in
WHO’s 2014 framework for intensified control [14], yet none of the currently available models
have been validated against data from field trials of T. solium control interventions. In this
research, we developed a novel transmission model for T. solium called CystiAgent, and vali-
dated the model using data from a large cluster-randomized trial of ring and mass-applied phar-
maceutical intervention conducted in northern Peru. Validation results showed that CystiAgent
could be accurately calibrated to reflect baseline levels of T. solium transmission, but overesti-
mated the magnitude of intervention effects in most villages. Despite this, the current validation
allowed for identification of potential gaps in the model that may be addressed in future ver-
sions, and represented an important step towards delivering an accurate and validated model
that can be used to answer key questions about T. solium transmission and control.
Fig 3. Simulation outcomes versus observed rates of human taeniasis, porcine cysticercosis and porcine seroincidence in the Ring Strategy Trial, by intervention
type (n = 21 villages). Plots display village-specific median simulated outcomes in CystiAgent across 1000 simulations per village, and observed outcomes from RST
(median value within intervention type in bold). For ring treatment (n = 6 villages), ring screening (n = 8 villages) and mass treatment (n = 7 villages villages),
intervention and without pig treatment are combined. See S1 Fig for sub-arm comparisons of villages with and without the addition of pig treatment.
https://doi.org/10.1371/journal.pntd.0009885.g003
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Baseline calibration
For this validation, CystiAgent was calibrated to each study village individually using the mod-
el’s eight tuning parameters and a complex ABC estimation method. Using this method, base-
line calibration was highly accurate in nearly all villages (median calibration errors of +0.09 and
+0.58 percentage points for taeniasis and porcine cysticercosis, respectively), which provided
assurance that the model could reproduce observed levels of endemic transmission. Two vil-
lages were excluded from the study because their small population size and lack of infected pigs
led to unstable transmission in the model; therefore, very small villages (<30 households) may
not be suitable for CystiAgent. Estimation of tuning parameters separately for each village with
ABC estimation is computationally demanding, and may not be feasible for larger scale use of
CystiAgent to compare or evaluate T. solium control interventions. To address this limitation,
updates to CystiAgent that may be considered for future versions include reducing the number
of tuning parameters and fitting a single set of parameter values to prevalence levels averaged
across a larger geographic region. Such adjustments would benefit from additional sensitivity
analysis and validation to evaluate the impact of these changes on model performance.
Validation of intervention strategies
Validation of CystiAgent against RST interventions showed that the model was able to execute
all six intervention types (ring screening, ring treatment, and mass treatment; with and with-
out pig treatment) and reproduce observed declines in transmission; however the model over-
estimated the magnitude of intervention effects in the majority of villages tested. The median
Fig 4. Relative errors of porcine seroincidence during validation of CystiAgent against result from the Ring
Strategy Trial, by intervention type–ring treatment (n = 6 villages), ring screening (n = 8 villages), and mass
treatment (n = 7 villages). Each time point represents the 4-month cumulative seroincidence across the 24-month
trial period, as measured by enzyme-linked immune-electro transfer blot (EITB) in pigs. Error bars show inter-quartile
range for relative errors among village in each intervention. Within each intervention type, villages with and without
pig treatment are combined.
https://doi.org/10.1371/journal.pntd.0009885.g004
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trial-end prevalence for taeniasis and porcine cysticercosis simulated in CystiAgent were 0.53
percentage points lower (0.55% observed vs. 0% simulated) and 5.0 percentage points lower
(8.8% observed vs. 2.2% simulated) than the observed prevalences in RST, respectively.
There are a few possible explanations for this error that could be addressed with additional
data collection to improve CystiAgent performance. First, the efficacy of NSM for curing taeni-
asis may have been overestimated in the model. While the applied single-dose efficacy of
76.6% has been reported elsewhere [51], variations in manufacturer formulation and shelf-life
could impact the treatment efficacy. Such a difference would reduce the effectiveness of con-
trol interventions and could have contributed to the overestimated intervention effects pre-
dicted in CystiAgent. Second, heterogeneous non-participation in control intervention,
particularly if concentrated among persons at high-risk for T. solium infections, would reduce
the effectiveness of control interventions. In CystiAgent, treatment applications among simu-
lation participants was randomly assigned among eligible individuals without accounting for
systematic non-participation, which could have led to overestimation of intervention effective-
ness. Third, acquired immunity and resistance to T. solium infection in pigs was not included
in CystiAgent due to a lack of data to accurately parameterize this process. Pig immunity is
highly dynamic [33] and the number of pigs with acquired immunity in the population would
likely decrease as control interventions are applied due to lower levels of exposures to T. solium
eggs in the environment, which could lead to more rapid rebounds in transmission among
susceptible pigs after treatment applications. CystiAgent was not able to replicate these
dynamic changes in population-level resistance among pigs, which may have caused overesti-
mation of the intervention effects predicted by CystiAgent.
Model performance with respect to porcine seroincidence by round showed that the model
predicted steady declines in seroincidence after each successive intervention application for all
three intervention types. While this trajectory matched the observed patterns of decline in vil-
lages that received ring treatment and mass treatment interventions (despite overestimating
the magnitude of decline), villages that received the ring screening intervention experienced a
sharp initial decline in seroincidence followed by a leveling off at low levels of transmission
that was not replicated in the model. The mechanism underlying this sharp decline and subse-
quent leveling off in ring screening arms is not definitively known. Possible explanations for
not capturing this pattern in CystiAgent include a higher efficacy of NSM when used post-
screening (91.8% post-screening efficacy was applied in CystiAgent), or a higher degree of spa-
tial clustering among T. solium-infected humans and pigs than modeled.
Strengths and limitations
There are a few important strengths of this validation to highlight. First, we had access to all
data collected during RST, a unique opportunity that allowed for this validation to be con-
ducted. Using these data, the model was tested independently in 21 separate villages and 6
unique intervention types, leading to a robust assessment of the model’s accuracy in a variety
of transmission settings. The consistency of the model’s performance across all villages pro-
vides initial support for the generalizability of the model to other transmission settings. Sec-
ond, the spatially explicit structure of CystiAgent allowed us to evaluate ring interventions in
this validation. Ring interventions are spatially targeted strategies for T. solium control that
have shown promising results in field studies [27,32], and are not able to be evaluated in other
non-spatial T. solium models.
There are two main limitations of this validation study. First, baseline and trial-end mea-
sures of porcine cysticercosis prevalence were limited by the diagnostic methods used in RST.
CystiAgent estimated the prevalence of true cyst infection in pigs based on EITB serology
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because necroscopic examination to definitely diagnose cyst infection in pigs was not con-
ducted in RST. EITB serology is highly sensitive but poorly specific for detecting true cyst
infections [33,52]. Therefore, to approximate the prevalence of true cyst infection at baseline
and trial-end, we estimated that 44% of seropositive pigs based on EITB would be infected, a
figure based on two necropsy studies previously conducted in the region [34,35]. These nec-
ropsy studies were conducted in different pig populations in different regions of Peru that had
not received intervention programs, and may not have the same immune responses as pigs in
this trial. Also, we used the same conversion factor for EITB serology at baseline and trial-end,
but the diagnostic performance of EITB may change after interventions are applied due to
changing levels of immunity in the pig population. This effect was observed in a previous trial
in Peru [3], and could indicate that trial-end prevalence of cyst infection in RST was lower
than estimated, which would indicate that model predictions were more accurate than the
measured error-rates indicated. More research is needed to determine how treatment and dis-
ease control impacts population immunity and diagnostic performance such that these fea-
tures can be accounted for in future models. Secondly, parameters used for this validation
were primarily sourced from a single region of northern Peru (Piura region). While the depth
of data available from this region made it possible to develop and validate this detailed ABM,
some key parameters may differ in other endemic areas of the world, which could impact the
model’s accuracy when applied to these regions. Application of CystiAgent outside of northern
Peru, therefore, would benefit from local data to set appropriate values for key model parame-
ters such as latrine use, pig roaming ranges, and pig trading, which were identified as high pri-
ority parameter groups in prior sensitivity analyses conducted with CystiAgent [21].
Future research priorities
CystiAgent and other T. solium models will always be limited by uncertainty in the mecha-
nisms and dynamics of T. solium transmission, which could impact model accuracy and valid-
ity. Some of the more important gaps in knowledge that may impact transmission but are not
yet incorporated into CystiAgent include age-related differences in pig roaming and environ-
mental exposure to T. solium [39,53,54], distribution patterns of infected pork through black
market channels [55], and the possibility of vector-borne transmission of T. solium eggs via
dung beetles and flies [56,57]. Perhaps the most important aspect of T. solium transmission
not included in the model, however, is immunity. Due to insufficient knowledge of the mecha-
nisms of immunity, resistance, and susceptibility to T. solium infection in humans and pigs,
we were not able to incorporate these features into the model. As described above, this may
have contributed to the observed overestimation of intervention effects. Since probabilities of
infection in the model (i.e., tuning parameters) were estimated using levels of transmission
observed at baseline, the model is not able to account for changes in susceptibility or resistance
that may occur in response to control pressure when an intervention is applied. This feature
could be added to the model if appropriate data from experimental and/or field studies
becomes available. While these and many other factors are not yet features of CystiAgent, a
key advantage of its ABM structure is that it has the flexibility to incorporate these novel fea-
tures when data become available, and can serve as an accessible platform to develop and test
hypotheses about T. solium transmission dynamics.
Conclusion
In this research, we developed and validated a novel transmission model for T. solium called
CystiAgent. In this first large-scale validation of a T. solium transmission model, CystiAgent
was able to simulate levels of transmission observed at baseline in the validation villages, and
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adequately replicate the effects of control interventions in the majority of villages. Overall, the
model overestimated intervention effects in many of the villages tested. These imperfect
results, however, represent important data-points that can be used to adjust and improve
future versions of the model. Moving forward we will continue to test and improve the CystiA-
gent model using data available from interventions in Peru, and evaluate the generalizability of
the model through validation against data from other endemic regions. Ultimately, we aim to
use a final validated version of CystiAgent to evaluate available strategies for T. solium control
and deliver evidence-based recommendations that will meet the need for validated strategies
emphasized by WHO.
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Mar; 23(1):94–7. https://doi.org/10.1590/s1984-29612014014 PMID: 24728368
57. Lawson JR, Gemmell MA. Transmission of taeniid tapeworm eggs via blowflies to intermediate hosts.
Parasitology. 1990; 100 Pt 1:143–6. https://doi.org/10.1017/s0031182000060224 PMID: 2314928
PLOS NEGLECTED TROPICAL DISEASES Validation of CystiAgent, an agent-based model for Taenia solium in northern Peru
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009885 October 27, 2021 20 / 20
